1) core shell magnetic composite microsphere
核壳磁性复合微球
2) Core-shell magnetic composite microspheres
磁性核壳微球
3) Core-shell composite microspheres
核-壳复合微球
5) magnetic composite microsphere
磁性复合微球
1.
Preparation and characterization of magnetic composite microspheres with core-shell structure
核-壳结构磁性复合微球的制备与表征
2.
In this way, several kinds of SiO2-Fe3O4-P(NIPAM-co-AA) magnetic composite microspheres with different sur- face morphologies were prepared.
采用反相悬浮聚合法合成了丙烯酸(AA)含量不同的N-异丙基丙烯酰胺-丙烯酸共聚物P(NIPAM-co-AA)微凝胶,并以其作为微反应器,通过原位外源沉积法制备了一系列微米级、表面具有图案化结构的SiO2-Fe3O4-P(NIPAM-co-AA)磁性复合微球。
3.
The core-shell structured magnetic composite microspheres with poly(acrylic acid)-co-poly(methyl methacrylate)(PAA-PMMA) as shell and Fe3O4 as core were prepared by dispersion polymerization using divinylbenzene(DVB) as cross-linking agent,2,2 -azobisisobutyronitrile(AIBN) as initiator,p.
在该纳米颗粒存在的条件下,通过分散共聚制得了内部为Fe3O4,外层为二乙烯基苯(DVB)交联的聚丙烯酸-co-聚甲基丙烯酸甲酯(PAA-co-PMMA)磁性复合微球。
6) magnetic composite microspheres
磁性复合微球
1.
To find a kind of material for immunomagnetic carrier, chitosan magnetic composite microspheres(CMCM)were prepared by reverse microemulsion.
为了得到蛋白吸附性能良好的免疫磁性载体,文章用反相微乳的方法合成了壳聚糖磁性复合微球(Chitosanmagneticcompositemicrospheres简称CMCM),与常用的单体聚合法制备的聚苯乙烯磁性复合微球(Polystyrenemagneticcompositemicrospheres,简称PMCM)从粒径和表观形貌、微球铁含量、磁响应性、表面官能基团等性质做了对比表征,结果表明,CMCM是一种比PMCM更理想的免疫磁性微球载体材料。
2.
The research progress and the preparation methods of magnetic composite microspheres are re- viewed.
综合介绍了磁性复合微球的研究进展及目前常用的制备磁性复合微球的方法,总结了各种制备方法的优缺点和适用范围,并着重介绍了单体聚合法,最后展望了磁性复合微球的发展趋势。
3.
In this study,Ba-ferrite particles and PU were chosen to prepare BaFe_(12)O_(19)/PU magnetic composite microspheres combining with X-ray radioparency and high magnetic response of BaFe_(12)O_(19) and excellent elasitisity,good biocompability of PU polymer.
本论文针对现有磁性微球存在的磁性物质含量低、粒度不均一、表面缺乏活性功能基团、生物相容性差等缺点,选择钡铁氧体粒子和聚氨酯(PU)为研究对象,制备出了一种结合了BaFe_(12)O_(19)的X光显影性和PU高分子的高弹性、优良的生物相容性等优点的BaFe_(12)O_(19)/PU磁性复合微球,并对合成微球进行了表面改性,获得了表面氨基化、高磁性物质含量、粒度均一的磁性复合微球。
补充资料:可降解淀粉微球和生物降解白蛋白微球阻滞法
可降解淀粉微球和生物降解白蛋白微球阻滞法
介入放射学技术。介入性局部化疗之前,把二者注入靶动脉,可暂时减少动脉血流,再行化疗药物灌注,以减少血液冲刷,保持局部化疗药物浓度的技术。与其他中期和长期栓塞微球不同,DSM和BAM仅造成数十分钟的血流量减少,待其被降解后血流可恢复至以前水平。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条